Scarica l'app Stockscreener
220.65
0.21%
0.46
Precedente Chiudi:
$220.19
Aprire:
$220.29
Volume 24 ore:
551.08K
Relative Volume:
0.39
Capitalizzazione di mercato:
$6.94B
Reddito:
$302.00K
Utile/perdita netta:
$-117.10M
Rapporto P/E:
-19.82
EPS:
-11.13
Flusso di cassa netto:
$-129.13M
1 W Prestazione:
+0.13%
1M Prestazione:
+105.98%
6M Prestazione:
+809.52%
1 anno Prestazione:
+919.64%
Intervallo 1D:
$220.15
$220.78
Intervallo di 1 settimana:
$219.60
$220.78
Portata 52W:
$15.22
$221.20
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Nome
Cidara Therapeutics Inc
Settore
Industria
Telefono
858-752-6170
Indirizzo
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Confronta CDTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
220.65 | 6.92B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-17 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-16 | Iniziato | Morgan Stanley | Overweight |
| 2025-10-10 | Iniziato | JP Morgan | Overweight |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-12 | Iniziato | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Ripresa | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-08 | Iniziato | Guggenheim | Buy |
| 2024-08-14 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Ripresa | H.C. Wainwright | Buy |
| 2021-09-22 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Iniziato | Aegis Capital | Buy |
| 2019-09-04 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2018-07-26 | Iniziato | Citigroup | Buy |
| 2017-04-21 | Iniziato | Raymond James | Strong Buy |
| 2017-04-17 | Reiterato | H.C. Wainwright | Buy |
| 2017-04-12 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-04-11 | Ripresa | Wedbush | Outperform |
| 2017-02-22 | Reiterato | H.C. Wainwright | Buy |
| 2017-02-22 | Aggiornamento | WBB Securities | Sell → Hold |
| 2016-12-21 | Ripresa | Leerink Partners | Outperform |
| 2016-12-19 | Iniziato | H.C. Wainwright | Buy |
| 2016-09-23 | Downgrade | WBB Securities | Hold → Sell |
| 2015-10-09 | Aggiornamento | WBB Securities | Sell → Hold |
| 2015-05-11 | Iniziato | Jefferies | Buy |
| 2015-05-11 | Iniziato | Leerink Partners | Outperform |
| 2015-05-11 | Iniziato | Needham | Buy |
| 2015-05-11 | Iniziato | Wedbush | Outperform |
| 2015-04-23 | Iniziato | WBB Securities | Sell |
Mostra tutto
Cidara Therapeutics Inc Borsa (CDTX) Ultime notizie
Bain Capital Life Sciences Investors LLC Purchases 1,797,600 Shares of Cidara Therapeutics, Inc. $CDTX - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Cidara therapeutics COO Ward sells $2.19 million in stock By Investing.com - Investing.com South Africa
Cidara therapeutics COO Ward sells $2.19 million in stock - Investing.com
CEO Stein Surrenders 2,285 Of Cidara Therapeutics Inc [CDTX] - TradingView
Cidara Therapeutics’ Earnings Call Highlights CD388 Progress - MSN
Marshall Wace LLP Buys New Stake in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Analysts Shift to Hold as Cidara’s (CDTX) Recent Acquisition Deal Caps Upside - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Stempoint Capital LP Takes Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump - The Motley Fool
Vivo Capital LLC Boosts Stock Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Resolute Capital Asset Partners LLC Makes New $1.33 Million Investment in Cidara Therapeutics, Inc. $CDTX - MarketBeat
RedChip Companies Congratulates Former Client Cidara Therapeutics on Its $9.2 Billion Acquisition by Merck - Savannah Morning News
Best Biotech Stocks To Keep An Eye OnDecember 8th - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SMLR, MRSN, CDTX, and RYI - Sahm
Cidara Therapeutics (CDTX) price target increased by 18.53% to 220.19 - MSN
Is This Pharmaceutical Giant a Buy After a Major Acquisition? - Finviz
How Cidara Therapeutics Inc. (20D0) stock behaves under inflation pressureMarket Trend Report & Growth-Oriented Investment Plans - Newser
Best Biotech Stocks To ResearchDecember 1st - MarketBeat
Cidara Therapeutics (NASDAQ:CDTX) Sets New 1-Year HighStill a Buy? - MarketBeat
Cidara Therapeutics Earnings Notes - Trefis
Cidara Therapeutics stock hits 52-week high at 220.49 USD By Investing.com - Investing.com South Africa
Cidara Therapeutics stock hits 52-week high at 220.49 USD - Investing.com
Quadrature Capital Ltd Takes Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
How resilient is Cidara Therapeutics Inc. stock in market downturnsNew Guidance & High Accuracy Trade Signal Alerts - Newser
Merck Commits $9.2 Billion to Acquire Cidara Therapeutics - MSN
Gainers Report: How resilient is Cidara Therapeutics Inc stock in market downturns2025 Top Gainers & Expert-Curated Trade Recommendations - BỘ NỘI VỤ
The American biopharm company Merck plans to raise $8 billion through the sale of bonds - AKM.RU
Cidara Therapeutics (NASDAQ:CDTX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Ensign Peak Advisors Inc Takes $244,000 Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Will Cidara Therapeutics Inc. (20D0) stock hit Wall Street targetsEarnings Recap Report & AI Driven Stock Price Forecasts - Newser
Merck Kicks Off US Dollar Bond Sale to Help Fund Cidara Deal - Bloomberg.com
Merck seeks up to US$8 bil in US bond sale tied to Cidara deal — Bloomberg - The Edge Singapore
Geode Capital Management LLC Grows Stock Position in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Intech Investment Management LLC Acquires Shares of 9,002 Cidara Therapeutics, Inc. $CDTX - MarketBeat
Street Watch: Why Cidara Therapeutics Inc. stock attracts high net worth investors - BỘ NỘI VỤ
3,783 Shares in Cidara Therapeutics, Inc. $CDTX Bought by Police & Firemen s Retirement System of New Jersey - MarketBeat
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer - AOL.com
Biotech Stocks To ConsiderNovember 25th - MarketBeat
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the MergerEXAS, SEE, CDTX, and MRSN - The Malaysian Reserve
hVIVO gains validation from Cidara’s takeover; broker calls it a "glowing endorsement" - Proactive Investors
Why Cidara Therapeutics Inc. stock attracts high net worth investors2025 Biggest Moves & Entry Point Confirmation Signals - BỘ NỘI VỤ
hVIVO PLCMSD to acquire Cidara - Research Tree
hVIVO welcomes MSD’s move to acquire Cidara in $9.2 billion deal - Vox Markets
hVIVO hails $9.2 billion Cidara takeover after key trial wins - Proactive financial news
Cidara Therapeutics Inc Azioni (CDTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cidara Therapeutics Inc Azioni (CDTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ward Shane | COO & CLO |
Dec 10 '25 |
Sale |
220.08 |
9,959 |
2,191,747 |
25,033 |
| Davarpanah Nicole Negar | Chief Medical Officer |
Sep 11 '25 |
Sale |
62.86 |
474 |
29,797 |
31,418 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Jun 26 '25 |
Buy |
44.00 |
2,272,727 |
99,999,988 |
3,365,523 |
| Mineo Chrysa | Director |
Jun 02 '25 |
Buy |
21.71 |
2,270 |
49,281 |
2,270 |
| Mineo Chrysa | Director |
Jun 03 '25 |
Buy |
23.44 |
1,050 |
24,614 |
3,320 |
| Ward Shane | COO & CLO |
Mar 11 '25 |
Sale |
21.96 |
1,664 |
36,542 |
14,674 |
| Tari Leslie | CHIEF SCIENTIFIC OFFICER |
Mar 11 '25 |
Sale |
21.96 |
1,773 |
38,940 |
16,215 |
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):